Otezla 55513-0519-30
Generic: Apremilast
- Manufacturer
- Amgen, Inc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 31, 2025
- Listing Expires
- December 31, 2027
- Application
- NDA205437
Need to source Otezla? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Apremilast | 75 mg/1 |
Drug Class
Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitors [MoA]
Selected Package
55513-0519-30Selected30 TABLET, FILM COATED in 1 BOTTLE (55513-519-30)